BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9208902)

  • 1. Treatment of lethal midline granuloma type nasal T-cell lymphoma.
    Sakata K; Hareyama M; Ohuchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A
    Acta Oncol; 1997; 36(3):307-11. PubMed ID: 9208902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal midline granuloma-nasal natural killer/T-cell lymphoma.
    Mendenhall WM; Olivier KR; Lynch JW; Mendenhall NP
    Am J Clin Oncol; 2006 Apr; 29(2):202-6. PubMed ID: 16601443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nasal T-cell lymphoma of the lethal midline type. Case report and current aspects in the literature].
    Ullrich D; Wildfang I; Karstens JH; Schröder M
    HNO; 1999 May; 47(5):490-3. PubMed ID: 10412659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from China and Japan.
    Mishima K; Horiuchi K; Kojya S; Takahashi H; Ohsawa M; Aozasa K
    Cancer; 1994 Jun; 73(12):3041-6. PubMed ID: 8200002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period.
    Chen HH; Fong L; Su IJ; Ting LL; Hong RL; Leung HW; Lui LT
    Radiother Oncol; 1996 Jan; 38(1):1-6. PubMed ID: 8850419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype.
    Aozasa K; Ohsawa M; Tomita Y; Tagawa S; Yamamura T
    Cancer; 1995 Feb; 75(3):894-901. PubMed ID: 7828140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of localized non-Hodgkin's lymphomas of the head and neck: focusing on cases of non-lethal midline granuloma.
    Sakata K; Hareyama M; Oouchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A; Hinoda Y
    Radiat Oncol Investig; 1998; 6(4):161-9. PubMed ID: 9727875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiocentric T/NK cell lymphoma: a special clinical-pathological entity of lethal midline granuloma. A case report].
    Koch M; Blatterspiel GJ; Niedobitek G; Constantinidis J
    Laryngorhinootologie; 2001 Jul; 80(7):410-5. PubMed ID: 11488153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating intercellular adhesion molecule-1 and its cellular expression in head and neck non-Hodgkin's lymphomas, including lethal midline granuloma.
    Harabuchi Y; Kataura A; Imai K
    Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):634-42. PubMed ID: 8712635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lethal midline granuloma: impact of imaging studies on the investigation and management of destructive mid facial disease in 13 patients.
    Marsot-Dupuch K; Cabane J; Raveau V; Aoun N; Tubiana JM
    Neuroradiology; 1992; 34(2):155-61. PubMed ID: 1603316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiocentric T-cell lymphoma presenting as lethal midline granuloma.
    Lee PY; Freeman NJ; Khorsand J; Weinstock MA
    Int J Dermatol; 1997 Jun; 36(6):419-27. PubMed ID: 9248885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal peripheral T-cell lymphoma: a 20-year review of cases treated in Scotland.
    Senan S; Symonds RP; Brown IL
    Clin Oncol (R Coll Radiol); 1992 Mar; 4(2):96-100. PubMed ID: 1554633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nasal T-cell lymphoma as a differential diagnosis of the midline granuloma syndrome].
    Tigges G; Delank KW; Blasius S; Stoll W
    Laryngorhinootologie; 1999 Mar; 78(3):139-43. PubMed ID: 10226981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
    Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
    Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal T-cell lymphoma and the lethal midline granuloma syndrome.
    Hartig G; Montone K; Wasik M; Chalian A; Hayden R
    Otolaryngol Head Neck Surg; 1996 Apr; 114(4):653-6. PubMed ID: 8643282
    [No Abstract]   [Full Text] [Related]  

  • 16. Malignant histiocytosis presenting as lethal midline granuloma: immunohistological study.
    Aozasa K; Inoue A
    J Pathol; 1982 Nov; 138(3):241-9. PubMed ID: 6752361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant centrofacial granulomas.
    Senan S
    Laryngoscope; 1992 Apr; 102(4):472. PubMed ID: 1556901
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiotherapy of midline malignant reticulosis.
    Gong Y
    Chin Med J (Engl); 1995 Jul; 108(7):542-3. PubMed ID: 7555275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.
    Ribrag V; Ell Hajj M; Janot F; Girinsky T; Domenge C; Schwaab G; Fenaux P; Bosq J
    Leukemia; 2001 Jul; 15(7):1123-6. PubMed ID: 11455983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal NK/T cell lymphoma presenting as a lethal midline granuloma.
    Mehta V; Balachandran C; Bhat S; Geetha V; Fernandes D
    Indian J Dermatol Venereol Leprol; 2008; 74(2):145-7. PubMed ID: 18388376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.